The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial
Publication
, Conference
Fanaroff, AC; Peterson, ED; Kaltenbach, LA; Cannon, CP; Choudhry, NK; Henry, TD; Anstrom, KJ; Cohen, DJ; Fonseca, E; Khan, ND; Fonarow, GC; Wang, TY
Published in: CIRCULATION
2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Fanaroff, A. C., Peterson, E. D., Kaltenbach, L. A., Cannon, C. P., Choudhry, N. K., Henry, T. D., … Wang, T. Y. (2018). The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial. In CIRCULATION (Vol. 138).
Fanaroff, Alexander C., Eric D. Peterson, Lisa A. Kaltenbach, Christopher P. Cannon, Niteesh K. Choudhry, Timothy D. Henry, Kevin J. Anstrom, et al. “The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial.” In CIRCULATION, Vol. 138, 2018.
Fanaroff AC, Peterson ED, Kaltenbach LA, Cannon CP, Choudhry NK, Henry TD, et al. The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial. In: CIRCULATION. 2018.
Fanaroff, Alexander C., et al. “The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial.” CIRCULATION, vol. 138, 2018.
Fanaroff AC, Peterson ED, Kaltenbach LA, Cannon CP, Choudhry NK, Henry TD, Anstrom KJ, Cohen DJ, Fonseca E, Khan ND, Fonarow GC, Wang TY. The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial. CIRCULATION. 2018.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology